Scinai Immunotherapeutics has appointed Eran Kuratz as Head of Supply Chain and Business Process Administration for its CDMO subsidiary, Scinai Biopharma Services. Kuratz brings over 30 years of experience in supply chain and operations across pharma and biotech sectors. His role will enhance coordination, operational discipline, and scalable processes across Scinai's expanded CDMO platform, which now includes two sites in Jerusalem and Yavne after acquiring Recipharm Israel. This move supports Scinai's goal to strengthen infrastructure and drive growth in its contract development and manufacturing services.
Investec Bank Plc, acting as advisor and joint broker to Advanced Medical Solutions Group Plc, disclosed its share transactions on August 7, 2026. The bank purchased 9,541 ordinary shares at 281.25 per share and sold 147,431 shares between 281 and 28...
Berkshire Hathaway reported a $1.8 billion increase in operating earnings last quarter, with a significant $1.2 billion portion attributed to favorable currency exchange movements. This currency impact notably boosted the company's financial results,...
The global Travel Now Pay Later (TNPL) market, valued at $45 billion in 2024, is projected to reach $77.6 billion by 2030, growing at a 9.5% CAGR. TNPL allows travelers to book flights, hotels, and tours with flexible installment payments, boosting b...
The healthcare sector has led all S&P 500 sectors with a 13.10% gain over the past three months, despite lagging year-to-date. Major pharmaceutical companies Eli Lilly, Johnson & Johnson, and AbbVie offer a mix of growth and income, with strong recen...
Boeing is selling three subsidiaries—Wisk Aero, SkyGrid, and Insitu—to Archer Aviation in exchange for an undisclosed stake in the eVTOL startup. This move allows Boeing to focus on its core commercial airplanes, defense, and space operations while h...
